Healio8h
FDA grants priority review to oral non-small cell lung cancer drug
The FDA granted priority review to a new drug application for sunvozertinib as an oral treatment for certain patients with ...
FDA approves Gemtesa for overactive bladder in men with benign prostatic hyperplasia
Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...
Benzinga.com1d
Best Stocks Under $20
If you're interested in exploring more stocks under $20 get an edge over other traders with Benzinga Pro while we're currently offering a 14-day trial. Stocks under $20 offer investors and ...
clinicaladvisor.com1d
Prostate Cancer Treatment Challenge: Which Drugs to Use First
A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...
moneycontrol.com2d
20 Microns Ltd.
Note :Financial Information is based on consolidated numbers.